LifeAssays AB (LIFE B)-医療機器分野:企業M&A・提携分析

◆英語タイトル:LifeAssays AB (LIFE B) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011136
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
LifeAssays AB (LifeAssays) is a medical device company that develops, manufactures and markets in-vitro diagnostic and veterinary care products. The company provides point-of-care diagnostic testing systems. Its product portfolio includes lifeassays human system and lifeassays veterinary systems, among others. LifeAssays’ human system offers solutions for measuring biological markers. The company’s VetReader System provides an alternative for POC testing utilizing the unique and patented magnetic immunoassay (MIA) technique. It offers its point-of-care diagnostic testing equipment for community, health centres, primary physicians and veterinarians. The company markets products through a network of distributors across Europe. LifeAssays is headquartered in Lund, Sweden.

LifeAssays AB (LIFE B) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
LifeAssays AB, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
LifeAssays AB, Medical Equipment Deals By Type, 2011 to YTD 2017 6
LifeAssays AB, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
LifeAssays AB, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
LifeAssays AB, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
LifeAssays AB, Medical Equipment, Deal Details 10
Partnerships 10
LifeAssays Enters into Agreement with Dynamics Biotech 10
Equity Offering 11
LifeAssays Raises USD0.5 Million in Private Placement of Shares up on Exercise of Warrants 11
LifeAssays Raises USD2 Million in Rights offering of Units 12
LifeAssays Raises USD2 Million in Rights Offering of Shares 13
LifeAssays Raises USD3.2 Million in Issue of Preferential Rights 14
LifeAssays Completes Rights Issue Of US$2.5 Million 15
LifeAssays Completes Rights Issue Of Common Stock For US$1.5 Million 16
Acquisition 17
LifeAssays Acquires Magnasense Technologies for USD0.5 Million 17
LifeAssays AB – Key Competitors 18
LifeAssays AB – Key Employees 19
LifeAssays AB – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
LifeAssays AB, Medical Equipment, Key Facts, 2016 2
LifeAssays AB, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
LifeAssays AB, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
LifeAssays AB, Medical Equipment Deals By Type, 2011 to YTD 2017 6
LifeAssays AB, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
LifeAssays AB, Deals By Market, 2011 to YTD 2017 8
LifeAssays AB, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
LifeAssays Enters into Agreement with Dynamics Biotech 10
LifeAssays Raises USD0.5 Million in Private Placement of Shares up on Exercise of Warrants 11
LifeAssays Raises USD2 Million in Rights offering of Units 12
LifeAssays Raises USD2 Million in Rights Offering of Shares 13
LifeAssays Raises USD3.2 Million in Issue of Preferential Rights 14
LifeAssays Completes Rights Issue Of US$2.5 Million 15
LifeAssays Completes Rights Issue Of Common Stock For US$1.5 Million 16
LifeAssays Acquires Magnasense Technologies for USD0.5 Million 17
LifeAssays AB, Key Competitors 18
LifeAssays AB, Key Employees 19
LifeAssays AB, Subsidiaries 20

★海外企業調査レポート[LifeAssays AB (LIFE B)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Tosk Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Tosk Inc (Tosk) is a drug developing company that provides development of safety and efficacy conditions of drugs. The company discovers and develops new drugs for cancer and other conditions using non-mammalian animal species as models for human diseases. It provides optimizing marketed dru …
  • Landec Corp (LNDC):企業の財務・戦略的SWOT分析
    Summary Landec Corp (Landec) is a diversified health solution service provider. The company offers offers food and biomaterial solutions. It develops and markets innovative and proprietary based products for healthy living. The company offers various technologies such as application development and …
  • Arsenal Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Arsenal Medical Inc (Arsenal) is a platform technology company that develops novel therapeutic polymer based foams. The company’s products include in-situ forming materials, in-situ forming polymeric foam and in-situ curing elastomeric polymer material. It offers in-situ forming materials to …
  • Greencore Group Plc:企業の戦略・SWOT・財務情報
    Greencore Group Plc - Strategy, SWOT and Corporate Finance Report Summary Greencore Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Sunquest Information Systems Inc:企業の戦略的SWOT分析
    Sunquest Information Systems Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • China Suntien Green Energy Co Ltd (956):電力:M&Aディール及び事業提携情報
    Summary China Suntien Green Energy Co Ltd (China Suntien) is a power generation company that explores and utilizes clean and new energy. It invests in the development and usage of natural gas, coal gas, and coal bed methane. China Suntien sells natural gas and provides natural gas pipelines construc …
  • The Kansai Electric Power Company Inc (9503)-エネルギー分野:企業M&A・提携分析
    Summary The Kansai Electric Power Company Inc (KEPCo) is an integrated power utility. The company produces and supplies electricity; and procures and sells natural gas. It generates electricity from natural gas, oil, nuclear, coal, hydro, wind, and solar sources. Through long, medium, and short term …
  • Delta Apparel, Inc. (DLA):企業の財務・戦略的SWOT分析
    Delta Apparel, Inc. (DLA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Deutsche Borse AG:企業のM&A・事業提携・投資動向
    Deutsche Borse AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Deutsche Borse AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • VIA Technologies, Inc (2388):企業の財務・戦略的SWOT分析
    VIA Technologies, Inc (2388) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Syros Pharmaceuticals Inc (SYRS):企業の財務・戦略的SWOT分析
    Summary Syros Pharmaceuticals Inc (Syros) is a biopharmaceutical company that develops medicines for the treatment of cancer, immune-mediated diseases, and other diseases. The company offers its pipeline products under clinical trials include SY-1425, an oral, potent and selective RARa agonist that …
  • Tohoku Electric Power Co Inc:発電所・企業SWOT分析
    Tohoku Electric Power Co Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Ubisoft Entertainment SA (UBI):企業の財務・戦略的SWOT分析
    Ubisoft Entertainment SA (UBI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • ImmusanT Inc-製薬・医療分野:企業M&A・提携分析
    Summary ImmusanT Inc (ImmusanT) is a drug company that discovers and develops therapies for celiac disease. The company’s pipeline products include Nexvax 2 and Nexvax 3. Its pipeline product Nexvax 2 is used for treating, preventing and diagnosing celiac disease. ImmusanT’s pipeline products are al …
  • Singapore Technologies Marine Ltd.:企業の戦略・SWOT・財務情報
    Singapore Technologies Marine Ltd. - Strategy, SWOT and Corporate Finance Report Summary Singapore Technologies Marine Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • MabVax Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary MabVax Therapeutics Inc (MabVax Therapeutics), a subsidiary of MabVax Therapeutics Holdings Inc is a biopharmaceutical company that develops and commercializes anti-cancer immunotherapies from antibody and vaccine technology. The company offers immune-oncology technology platforms such as hu …
  • Wake Forest Innovations-製薬・医療分野:企業M&A・提携分析
    Summary Wake Forest Innovations (Wake Forest), a subsidiary of Wake Forest Baptist Medical Center, is an enterprise that advances the development and commercialization of discoveries; services; and products such as medicines and vaccines, from the Medical Center and Wake Forest University. The compa …
  • Advent Software, Inc.:企業の戦略的SWOT分析
    Advent Software, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • American States Water Company (AWR):企業の財務・戦略的SWOT分析
    Summary American States Water Company (AWR) is a utility service provider that offers water, wastewater and electric services. The utility provides operation, construction management and maintenance services for water and wastewater systems located on military bases across the US. It offers water se …
  • Bord na Mona Plc:企業の戦略的SWOT分析
    Bord na Mona Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆